CHARLES RIVER LABORATORIES (CRL)       185.16  -2.35 (-1.25%)

185.16  -2.35 (-1.25%)

US1598641074 - Common Stock - After market: 185.16 0 (0%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q2 2022 2.77 2.76 0.010.30% Q1 2022 2.75 2.74 0.010.26% Q4 2021 2.49 2.46 0.031.35% Q3 2021 2.70 2.60 0.103.70% Q2 2021 2.61 2.40 0.218.57% Q1 2021 2.53 2.21 0.3214.27% Q4 2020 2.39 2.13 0.2612.40% Q3 2020 2.33 1.82 0.5128.20%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 10.90 10.33 5.49%Q3 2022 2.53 2.70 -6.44%Q4 2022 2.75 2.49 10.38%FY 2023 12.26 10.90 12.49%Q1 2023 2.82 2.75 2.42%Q2 2023 3.08 2.77 11.17%Q3 2023 3.04 2.53 20.23%Q4 2023 3.28 2.75 19.27%FY 2024 13.96 12.26 13.90%Q1 2024 2.92 2.82 3.63%Q2 2024 3.32 3.08 7.91%Q3 2024 3.28 3.04 8.08%Q4 2024 3.45 3.28 5.37%FY 2025 15.65 13.96 12.08%FY 2026 17.71 15.65 13.20%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q2 2022 973.131M 1.005B -31.767M-3.16% Q1 2022 913.929M 919.206M -5.277M-0.57% Q4 2021 905.05M 897.156M 7.894M0.88% Q3 2021 895.937M 912.228M -16.291M-1.79% Q2 2021 914.607M 889.249M 25.358M2.85% Q1 2021 824.6M 806.159M 18.441M2.29% Q4 2020 791M 764.432M 26.568M3.48% Q3 2020 743.3M 724.048M 19.252M2.66%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 3.924B 3.54B 10.83%Q3 2022 980.06M 895.937M 9.39%Q4 2022 1.031B 905.05M 13.92%FY 2023 4.259B 3.924B 8.55%Q1 2023 1.018B 913.929M 11.39%Q2 2023 1.061B 973.131M 9.03%Q3 2023 1.069B 980.06M 9.05%Q4 2023 1.101B 1.031B 6.75%FY 2024 4.659B 4.259B 9.40%Q1 2024 1.144B 1.018B 12.33%Q2 2024 1.25B 1.061B 17.84%Q3 2024 1.27B 1.069B 18.83%Q4 2024 1.323B 1.101B 20.20%FY 2025 5.027B 4.659B 7.89%FY 2026 5.478B 5.027B 8.97%